Pfizer Announces Results from Phase 3 Trial of Revatio (Sildenafil Citrate) in Newborns with Persistent Pulmonary Hypertension
NEW YORK--(BUSINESS WIRE)--Jun 28, 2019-- |!| Ludington
NEW YORK--(BUSINESS WIRE)--Jun 28, 2019-- |!| Ludington